Abrezekimab
Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding to IL-13Rα1 subunit. Abrezekimab can be used to study biological disorders associated with asthma and lung disease.
Product Specifications
CAS Number
2043952-59-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-7980R-FITC 100 µL
Beta glucuronidase Polyclonal Antibody, FITC Conjugated
Sign In for Pricing
View Details 043445 200 µL
TTPAL, CT (TTPAL, C20orf121, Alpha-tocopherol transfer protein-like)
Sign In for Pricing
View Details 
MBS9424510-01 96 Tests
Human anti-rubella virus IgM antibody, anti-RV IgM ELISA Kit
Sign In for Pricing
View Details MBS9424510-02 5x 96 Tests
Human anti-rubella virus IgM antibody, anti-RV IgM ELISA Kit
Sign In for Pricing
View Details